Earnings Call · Q2 FY2025·2025-08-12

Q2 25EPS +15.63%·Rev n/aQ1 25EPS +23.53%·Rev n/aQ4 24EPS +1.52%·Rev n/aQ3 24EPS +11.11%·Rev n/a⚠ consensus missing

Altimmune, Inc. ALT

Lee Roth — Investor Relations or Communications

Vipin Garg — Chief Executive Officer

Scott Harris — Chief Medical Officer

Greg Weaver — Chief Financial Officer

+7.1%1d on move date+6.0% vs SPY3d+8.9%5d+5.3%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ALT calls or request research access.

More ALT calls Browse calls Request research access